<code id='59C4E2E4AB'></code><style id='59C4E2E4AB'></style>
    • <acronym id='59C4E2E4AB'></acronym>
      <center id='59C4E2E4AB'><center id='59C4E2E4AB'><tfoot id='59C4E2E4AB'></tfoot></center><abbr id='59C4E2E4AB'><dir id='59C4E2E4AB'><tfoot id='59C4E2E4AB'></tfoot><noframes id='59C4E2E4AB'>

    • <optgroup id='59C4E2E4AB'><strike id='59C4E2E4AB'><sup id='59C4E2E4AB'></sup></strike><code id='59C4E2E4AB'></code></optgroup>
        1. <b id='59C4E2E4AB'><label id='59C4E2E4AB'><select id='59C4E2E4AB'><dt id='59C4E2E4AB'><span id='59C4E2E4AB'></span></dt></select></label></b><u id='59C4E2E4AB'></u>
          <i id='59C4E2E4AB'><strike id='59C4E2E4AB'><tt id='59C4E2E4AB'><pre id='59C4E2E4AB'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:78
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Health AI adoption puts security, privacy startups on investors' radar
          Health AI adoption puts security, privacy startups on investors' radar

          AdobeInvestorsarestartingtobackstartupsthatofferprivacyandsecurityservicestobolsterhealthAIproductsa

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Pfizer, Moderna say biotech, pharma drug development is a sprint

          Fromlefttoright,STAT'sDamianGarde;MikaelDolsten,chiefscientificofficerofPfizerresearchanddevelopment